findings

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease

SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…

2 months ago

Majority of Global Employers Remain Unprepared for Pay Transparency Laws, Aon Finds

Organizations remain focused on compliance rather than embracing transparency as a strategic priority DUBLIN, July 10, 2025 /PRNewswire/ -- Aon…

5 months ago

Despite Global Headwinds, Domestic Demand and Prudent Investment drive Small Business Optimism- ASSOCHAM-Dun & Bradstreet’s Small Business Confidence Index

MUMBAI, India, June 13, 2025 /PRNewswire/ -- ASSOCHAM along with Dun & Bradstreet, a leading global provider of business decisioning data…

5 months ago

ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy

VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal…

6 months ago